Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5205156
Max Phase: Preclinical
Molecular Formula: C23H34O2
Molecular Weight: 342.52
Associated Items:
ID: ALA5205156
Max Phase: Preclinical
Molecular Formula: C23H34O2
Molecular Weight: 342.52
Associated Items:
Canonical SMILES: CCOc1ccc2c(c1)C[C@@H]1[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]1(C)O2
Standard InChI: InChI=1S/C23H34O2/c1-6-24-17-8-9-18-16(14-17)15-20-22(4)12-7-11-21(2,3)19(22)10-13-23(20,5)25-18/h8-9,14,19-20H,6-7,10-13,15H2,1-5H3/t19-,20+,22-,23+/m0/s1
Standard InChI Key: UUXZXQZQYDJVFM-PABCKOPISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 342.52 | Molecular Weight (Monoisotopic): 342.2559 | AlogP: 6.02 | #Rotatable Bonds: 2 |
Polar Surface Area: 18.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.95 | CX LogD: 5.95 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.65 | Np Likeness Score: 1.85 |
1. Wang X, Hu N, Kong W, Song B, Li S.. (2022) Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads., 227 [PMID:34653771] [10.1016/j.ejmech.2021.113912] |
Source(1):